Parecoxib is a water-soluble and injectable prodrug of valdecoxib. It is marketed as Dynastat in the European Union. Parecoxib is a COX2 selective inhibitor in the same category as celecoxib (Celebrex) and rofecoxib (Vioxx). As it is injectable, it can be used perioperatively when patients are unable to take oral medications. It is approved through much of Europe for short term perioperative pain control much in the same way ketorolac (Toradol) is used in the United States. A letter of non-approval for parecoxib was issued by the FDA in 2005.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Amlodipine | The metabolism of Parecoxib can be decreased when combined with Amlodipine. |
| Midodrine | The risk or severity of hypertension can be increased when Midodrine is combined with Parecoxib. |
| Isoetharine | The risk or severity of hypertension can be increased when Isoetharine is combined with Parecoxib. |
| Zolmitriptan | The risk or severity of hypertension can be increased when Zolmitriptan is combined with Parecoxib. |
| Norepinephrine | The risk or severity of hypertension can be increased when Norepinephrine is combined with Parecoxib. |
| Phenylephrine | The risk or severity of hypertension can be increased when Phenylephrine is combined with Parecoxib. |
| Phenylpropanolamine | The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Parecoxib. |
| Droperidol | The risk or severity of hypertension can be increased when Droperidol is combined with Parecoxib. |
| Doxapram | The risk or severity of hypertension can be increased when Doxapram is combined with Parecoxib. |
| Atropine | The risk or severity of hypertension can be increased when Atropine is combined with Parecoxib. |
| Linezolid | The risk or severity of hypertension can be increased when Linezolid is combined with Parecoxib. |
| Metaraminol | The risk or severity of hypertension can be increased when Metaraminol is combined with Parecoxib. |
| Furazolidone | The risk or severity of hypertension can be increased when Furazolidone is combined with Parecoxib. |
| Thioridazine | The risk or severity of hypertension can be increased when Thioridazine is combined with Parecoxib. |
| Nicergoline | The risk or severity of hypertension can be increased when Nicergoline is combined with Parecoxib. |
| Methoxamine | The risk or severity of hypertension can be increased when Methoxamine is combined with Parecoxib. |
| Isoflurane | The risk or severity of hypertension can be increased when Isoflurane is combined with Parecoxib. |
| Propiomazine | The risk or severity of hypertension can be increased when Propiomazine is combined with Parecoxib. |
| Minaprine | The risk or severity of hypertension can be increased when Minaprine is combined with Parecoxib. |
| Orciprenaline | The risk or severity of hypertension can be increased when Orciprenaline is combined with Parecoxib. |
| Phenmetrazine | The risk or severity of hypertension can be increased when Phenmetrazine is combined with Parecoxib. |
| Trifluoperazine | The risk or severity of hypertension can be increased when Trifluoperazine is combined with Parecoxib. |
| Pseudoephedrine | The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Parecoxib. |
| Ritodrine | The risk or severity of hypertension can be increased when Ritodrine is combined with Parecoxib. |
| Flupentixol | The risk or severity of hypertension can be increased when Flupentixol is combined with Parecoxib. |
| Remifentanil | The risk or severity of hypertension can be increased when Remifentanil is combined with Parecoxib. |
| Bitolterol | The risk or severity of hypertension can be increased when Bitolterol is combined with Parecoxib. |
| Oxymetazoline | The risk or severity of hypertension can be increased when Oxymetazoline is combined with Parecoxib. |
| Diethylpropion | The risk or severity of hypertension can be increased when Diethylpropion is combined with Parecoxib. |
| Naratriptan | The risk or severity of hypertension can be increased when Naratriptan is combined with Parecoxib. |
| Frovatriptan | The risk or severity of hypertension can be increased when Frovatriptan is combined with Parecoxib. |
| Isoprenaline | The risk or severity of hypertension can be increased when Isoprenaline is combined with Parecoxib. |
| Arbutamine | The risk or severity of hypertension can be increased when Arbutamine is combined with Parecoxib. |
| Desflurane | The risk or severity of hypertension can be increased when Desflurane is combined with Parecoxib. |
| Isocarboxazid | The risk or severity of hypertension can be increased when Isocarboxazid is combined with Parecoxib. |
| Lisdexamfetamine | The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Parecoxib. |
| Fenoterol | The risk or severity of hypertension can be increased when Fenoterol is combined with Parecoxib. |
| Pirbuterol | The risk or severity of hypertension can be increased when Pirbuterol is combined with Parecoxib. |
| Ephedra sinica root | The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Parecoxib. |
| Ephedrine | The risk or severity of hypertension can be increased when Ephedrine is combined with Parecoxib. |
| Mephentermine | The risk or severity of hypertension can be increased when Mephentermine is combined with Parecoxib. |
| Procaterol | The risk or severity of hypertension can be increased when Procaterol is combined with Parecoxib. |
| Methotrimeprazine | The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Parecoxib. |
| Clenbuterol | The risk or severity of hypertension can be increased when Clenbuterol is combined with Parecoxib. |
| Bambuterol | The risk or severity of hypertension can be increased when Bambuterol is combined with Parecoxib. |
| MMDA | The risk or severity of hypertension can be increased when MMDA is combined with Parecoxib. |
| Midomafetamine | The risk or severity of hypertension can be increased when Midomafetamine is combined with Parecoxib. |
| 2,5-Dimethoxy-4-ethylamphetamine | The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Parecoxib. |
| 4-Methoxyamphetamine | The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Parecoxib. |
| 4-Bromo-2,5-dimethoxyamphetamine | The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Parecoxib. |
| Tenamfetamine | The risk or severity of hypertension can be increased when Tenamfetamine is combined with Parecoxib. |
| Chlorphentermine | The risk or severity of hypertension can be increased when Chlorphentermine is combined with Parecoxib. |
| Dextroamphetamine | The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Parecoxib. |
| Phendimetrazine | The risk or severity of hypertension can be increased when Phendimetrazine is combined with Parecoxib. |
| Periciazine | The risk or severity of hypertension can be increased when Periciazine is combined with Parecoxib. |
| Acepromazine | The risk or severity of hypertension can be increased when Acepromazine is combined with Parecoxib. |
| Thioproperazine | The risk or severity of hypertension can be increased when Thioproperazine is combined with Parecoxib. |
| Epicaptopril | The risk or severity of hypertension can be increased when Epicaptopril is combined with Parecoxib. |
| Clorgiline | The risk or severity of hypertension can be increased when Clorgiline is combined with Parecoxib. |
| 1-benzylimidazole | The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Parecoxib. |
| Nialamide | The risk or severity of hypertension can be increased when Nialamide is combined with Parecoxib. |
| Amibegron | The risk or severity of hypertension can be increased when Amibegron is combined with Parecoxib. |
| Naluzotan | The risk or severity of hypertension can be increased when Naluzotan is combined with Parecoxib. |
| Pizotifen | The risk or severity of hypertension can be increased when Pizotifen is combined with Parecoxib. |
| Solabegron | The risk or severity of hypertension can be increased when Solabegron is combined with Parecoxib. |
| Esmirtazapine | The risk or severity of hypertension can be increased when Esmirtazapine is combined with Parecoxib. |
| Nitrous oxide | The risk or severity of hypertension can be increased when Nitrous oxide is combined with Parecoxib. |
| Xylometazoline | The risk or severity of hypertension can be increased when Xylometazoline is combined with Parecoxib. |
| Dexmethylphenidate | The risk or severity of hypertension can be increased when Dexmethylphenidate is combined with Parecoxib. |
| Isometheptene | The risk or severity of hypertension can be increased when Isometheptene is combined with Parecoxib. |
| Levonordefrin | The risk or severity of hypertension can be increased when Levonordefrin is combined with Parecoxib. |
| Naphazoline | The risk or severity of hypertension can be increased when Naphazoline is combined with Parecoxib. |
| Tetryzoline | The risk or severity of hypertension can be increased when Tetryzoline is combined with Parecoxib. |
| Cinitapride | The risk or severity of hypertension can be increased when Parecoxib is combined with Cinitapride. |
| Tyramine | The risk or severity of hypertension can be increased when Parecoxib is combined with Tyramine. |
| Adrafinil | The risk or severity of hypertension can be increased when Parecoxib is combined with Adrafinil. |
| Isoxsuprine | The risk or severity of hypertension can be increased when Parecoxib is combined with Isoxsuprine. |
| Ifenprodil | The risk or severity of hypertension can be increased when Parecoxib is combined with Ifenprodil. |
| Hexoprenaline | The risk or severity of hypertension can be increased when Parecoxib is combined with Hexoprenaline. |
| Etilefrine | The risk or severity of hypertension can be increased when Parecoxib is combined with Etilefrine. |
| Cirazoline | The risk or severity of hypertension can be increased when Parecoxib is combined with Cirazoline. |
| Synephrine | The risk or severity of hypertension can be increased when Parecoxib is combined with Synephrine. |
| Hydracarbazine | The risk or severity of hypertension can be increased when Parecoxib is combined with Hydracarbazine. |
| Benmoxin | The risk or severity of hypertension can be increased when Parecoxib is combined with Benmoxin. |
| Mebanazine | The risk or severity of hypertension can be increased when Parecoxib is combined with Mebanazine. |
| Octamoxin | The risk or severity of hypertension can be increased when Parecoxib is combined with Octamoxin. |
| Pheniprazine | The risk or severity of hypertension can be increased when Parecoxib is combined with Pheniprazine. |
| Phenoxypropazine | The risk or severity of hypertension can be increased when Parecoxib is combined with Phenoxypropazine. |
| Pivhydrazine | The risk or severity of hypertension can be increased when Parecoxib is combined with Pivhydrazine. |
| Safrazine | The risk or severity of hypertension can be increased when Parecoxib is combined with Safrazine. |
| Caroxazone | The risk or severity of hypertension can be increased when Parecoxib is combined with Caroxazone. |
| Doxofylline | The risk or severity of hypertension can be increased when Parecoxib is combined with Doxofylline. |
| Iofetamine I-123 | The risk or severity of hypertension can be increased when Parecoxib is combined with Iofetamine I-123. |
| Racepinephrine | The risk or severity of hypertension can be increased when Parecoxib is combined with Racepinephrine. |
| Amitraz | The risk or severity of hypertension can be increased when Parecoxib is combined with Amitraz. |
| Medetomidine | The risk or severity of hypertension can be increased when Parecoxib is combined with Medetomidine. |
| Xylazine | The risk or severity of hypertension can be increased when Parecoxib is combined with Xylazine. |
| Atipamezole | The risk or severity of hypertension can be increased when Parecoxib is combined with Atipamezole. |
| Ractopamine | The risk or severity of hypertension can be increased when Parecoxib is combined with Ractopamine. |
| Romifidine | The risk or severity of hypertension can be increased when Parecoxib is combined with Romifidine. |